Tumor Infiltrating Cells | List of Frontiers open access articles

Original Research

Published on 19 Jul 2022

The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA)

in Pharmacology of Anti-Cancer Drugs

Ruiyan Xie
Ming Xie
Litong Zhu
Joanne W. Y. Chiu
Wayne Lam
Desmond Y. H. Yap

Frontiers in Pharmacology

doi 10.3389/fphar.2022.930951

4,443 views
6 citations

Original Research

Published on 28 Jan 2026

Multi-omics characterization of RNA modification enzymes identifies NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Qianqian Zhan
Huihui Sun
Xiangting Wang
Xiaolin Liang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1764106

729 views

Original Research

Published on 10 Nov 2023

A novel immune-related risk-scoring system associated with the prognosis and response of cervical cancer patients treated with radiation therapy

in Molecular Diagnostics and Therapeutics

Zhuna Wu
Qiuya Lin
Liying Sheng
Weihong Chen
Meili Liang
Danni Wu
Yumin Ke

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1297774

3,336 views
3 citations

Original Research

Published on 14 Oct 2021

TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment

in Cancer Genetics and Oncogenomics

Hua Zhu
Xinyao Hu
Lijuan Gu
Zhihong Jian
Liqin Li
Siping Hu
Sheng Qiu
Xiaoxing Xiong

Frontiers in Genetics

doi 10.3389/fgene.2021.759953

10,648 views
59 citations

Original Research

Published on 07 Jul 2022

Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma

in Cancer Genetics

Jun Zhu
Tenghui Han
Shoujie Zhao
Yejing Zhu
Shouzheng Ma
Fenghua Xu
Tingting Bai
Yuxin Tang
Yungang Xu
Lei Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.933210

4,236 views
4 citations

Original Research

Published on 12 Oct 2018

Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers

in Cancer Immunity and Immunotherapy

Xiang Hu
Ya-Qi Li
Qing-Guo Li
Yan-Lei Ma
Jun-Jie Peng
San-Jun Cai

Frontiers in Immunology

doi 10.3389/fimmu.2018.02354

5,996 views
20 citations

Original Research

Published on 10 Dec 2024

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab

in Cancer Immunity and Immunotherapy

Jaejun Lee
Jae-Sung Yoo
Ji Hoon Kim
Dong Yeup Lee
Keungmo Yang
Bohyun Kim
Joon-Il Choi
Jeong Won Jang
Jong Young Choi
Seung Kew Yoon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506355

3,832 views
6 citations

Original Research

Published on 27 Aug 2025

CS Ratio is an immune-related prognostic biomarker for cervical cancer

in Gynecological Oncology

Peiqin Shi
Wenwen Zhang
Qingqing Yao
Zhanna Yuan
Jiaqi Wang
Ziye Yang
Pengpeng Qu

Frontiers in Oncology

doi 10.3389/fonc.2025.1547529

2,343 views

Articles

The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA)

Multi-omics characterization of RNA modification enzymes identifies NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma

A novel immune-related risk-scoring system associated with the prognosis and response of cervical cancer patients treated with radiation therapy

TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment

Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma

Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab

CS Ratio is an immune-related prognostic biomarker for cervical cancer